Calidi Biotherapeutics Inc (CLDI)
0.197
0.00 (0.00%)
USD |
NYAM |
May 03, 16:00
0.1855
-0.01
(-5.84%)
After-Hours: 20:00
Calidi Biotherapeutics Total Assets (Quarterly): 10.02M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.02M |
| September 30, 2023 | 18.59M |
| June 30, 2023 | 10.18M |
| Date | Value |
|---|---|
| December 31, 2022 | 2.597M |
| September 30, 2022 | 1.618M |
| December 31, 2021 | 3.391M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.618M
Minimum
Sep 2022
18.59M
Maximum
Sep 2023
7.732M
Average
6.705M
Median
Total Assets (Quarterly) Benchmarks
| Minerva Neurosciences Inc | 56.90M |
| Viking Therapeutics Inc | 967.52M |
| Regenxbio Inc | 573.97M |
| CytomX Therapeutics Inc | 201.79M |
| Janux Therapeutics Inc | 380.41M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.25M |
| Shareholders Equity (Quarterly) | -8.235M |